Literature DB >> 2244776

Group B streptococcus endocarditis following second-trimester abortion.

M L Atri1, D H Cohen.   

Abstract

An 18-year-old woman who underwent an elective second-trimester abortion developed Streptococcus agalactiae (group B streptococcus) endocarditis characterized by a large, pedunculated vegetation involving a previously normal tricuspid valve. Polyarthritic symptoms, as well as multiple pulmonary emboli, were experienced, and cure followed a course of treatment using intravenous penicillin G potassium combined with gentamicin sulfate. Endocarditis caused by this pathogen usually occurs among individuals compromised by underlying chronic disorders and, today, is a rare sequela of pregnancy and abortion. When planning therapy, consideration should be given to the possibility of tolerance among clinical isolates and the need for operative intervention in selected patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2244776

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  4 in total

Review 1.  Postpartum culture negative endocarditis: a case report and review of the current guidelines.

Authors:  Omar F Ali; Natasha Ratnaraja; Nazim Nathani; Moninder Bhabra; Chetan Varma
Journal:  BMJ Case Rep       Date:  2011-10-04

2.  Group B Streptococcal Tricuspid Endocarditis: Case Report and Systematic Review.

Authors:  Perry Wengrofsky; Ghassan Mubarak; Nabila Khondakar; Syed Haseeb; David Landman; Suzette Graham-Hill; Angelina Zhyvotovska; Samy I McFarlane
Journal:  Scifed J Cardiol       Date:  2018-12-18

3.  Group B Streptococcus tricuspid valve endocarditis with subsequent septic embolization to the pulmonary artery: A case report following elective abortion.

Authors:  Sabrina Piedimonte; Mohammad Almohammadi; Todd C Lee
Journal:  Obstet Med       Date:  2017-09-01

4.  Group B streptococcal endocarditis in obstetric and gynecologic practice.

Authors:  Antonio Crespo; Avi S Retter; Bennett Lorber
Journal:  Infect Dis Obstet Gynecol       Date:  2003
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.